A new way: Alleviating postembolization syndrome following transcatheter arterial chemoembolization

Journal of Alternative and Complementary Medicine

Volumn 15, Issue 2, 2009, Pages 175-181

  Yinglu, Feng ^a   Changquan, Ling ^a,b   Xiaofeng, Zhai ^a   Bai, Li ^a   Dezeng, Zhu ^a   Zhe, Chen ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CAMPTOTHECIN DERIVATIVE; DEXAMETHASONE; EPIRUBICIN; FLUOROURACIL; GINSENOSIDE; IODINATED POPPYSEED OIL; PLACEBO;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CANCER COMBINATION CHEMOTHERAPY; CHEMOEMBOLIZATION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; FEVER; HUMAN; INCIDENCE; LIVER CANCER; LIVER DYSFUNCTION; LIVER FUNCTION; LIVER PAIN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NAUSEA; POSTEMBOLIZATION SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; ALANINE TRANSAMINASE; ANTINEOPLASTIC AGENTS; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; DEXAMETHASONE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FEVER; GINSENOSIDES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NAUSEA; PANAX; PHYTOTHERAPY; PLANT EXTRACTS; VOMITING;

EID: 60749085459     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2008.0093     Document Type: Article

References (33)

1. Trinchet JC, Rached AA, Beaugrand M. A comparison of Lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. NEJM 1995;332:1256-1261.
2. Vetter D, Wenger JJ, Bergier JM, et al. Transcatheter oily chemoembolization in the management of advanced hepatocellular carcinoma in cirrhosis: Results of a Western comparative study in 60 patients. Hepatology 1991;13:427-433.
3. Pelletier G, Roche A, Ink O, et al. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol 1990;11: 181-184.
4. Takayasu K, Arii S, Ikai I, et al. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 2006;131: 461-469.
5. Huang YS, Chiang JH, Wu JC, et al. Risk of hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma: Predictive value of the monoethylglycinexylidide test. Am J Gastroenterol 2002;97:1223-1227.
6. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-214.
7. Society of Liver Cancer of Chinese Anti-Cancer Association. Clinical diagnosis and staging criteria for primary liver cancer. Chin J Hepatol 2001;9:324.
8. Chuang VP, Wallace S, Soo CS, et al. Therapeutic Ivalon embolization of hepatic tumors. Am J Radiol 1982;138:289-294.
9. Coldwell DM, Mortimer JE. Hepatic artery embolization in the treatment of hepatic malignancies. Regional Cancer Treat 1991;3:298-301.
10. Coldwell DM, Mortimer JE. Transcatheter therapy for malignant neoplasms. West J Med 1999;151:299-303.
11. Seldinger SI. Catheter replacement of needle in percutaneous arteriography: A new technique. Acta Radiol 1989;39:368-372.
12. Zhou JC. Practice of Medical Oncology. Beijing: People's Medical Publishing House, 2003:424.
13. Mondazzi L, Bottelli R, Brambilla G, et al. Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: A multivariate analysis of prognostic factors. Hepatology 1994;19:1115-1123.
14. Jansen MC, van Hillegersberg R, Chamuleau RAFM, et al. Outcome of regional and local ablative therapies for hepatocellular carcinoma: A collective review. Eur J Surg Oncol 2005;31:331-347.
15. Nagano M, Nakamura T, Niimi S, et al. Substitution of arginine for cysteine 643 of the glucocorticoid receptor reduces its steroid-binding affinity and transcriptional activity. Cancer Lett 2002;181:109-114.
16. Distelhorst CW. Recent insights into the mechanism of glucocorticosteroid-induced apoptosis. Cell Death Differ 2002;9:6-19.
17. Oberleithner H, Riethmuller C, Ludwig T, et al. Differential action of steroid hormones on human endothelium. J Cell Sci 2006;119:1926-1932.
18. Tombran-Tink J, Lara N, Apricio SE, et al. Retinoic acid and dexamethasone regulate the expression of PEDF in retinal and endothelial cells. Exp Eye Res 2004;78:945-955.
19. Heron JF, Goedhals L, Jordaan JP, et al. Oral granisetron alone and in combination with dexamethasone: A double-blind randomized comparison against high-dose metoclopramide plus dexamethasone in prevention of cisplatin-induced emesis. Ann Oncol 1994;5:579-574.
20. Junmo W. Pharmacy research progression of ginseng. Ginseng Res 2001;13:2.
21. Yoon S-R, Nah J-J, Shin Y-H, et al. Ginsenosides induce differential antinociception and inhibit substance P induced-nociceptive response in mice. Life Sci 1998;62:319-325.
22. Jie YH, Cammisuli S, Baggiolini M. Immunomodulatory effects of Panax ginseng C.A. Meyer in the mouse. Agents Actions 1984;15:386-391.
23. Cho JY, Kim AR, Yoo ES, et al. Ginsenosides from Panax ginseng differentially regulate lymphocyte proliferation. Planta Med 2002;68:497-500.
24. Liu SJ, Zhou SW. Panax notoginseng saponins attenuated cisplatin-induced nephrotoxicity. Acta Pharmacol Sin 2000;21:257-260.
25. Lu NZ, Cidlowski JA. Glucocorticoid receptor isoforms generate transcription specificity. Trends Cell Bio 2006;16: 301-307.
26. Alexandrova M, Farkas P. Stress-induced changes of glucocorticoid receptor in rat liver. J Steroid Biochem Mol Biol 1992;42:493-498.
27. Herman JP, Watson SJ, Spencer RL. Defense of adrenocorticosteroid receptor expression in rat hippocampus: Effects of stress and strain. Endocrinology 1999;140:3981-3991.
28. Liu DH, Su YP, Zhang W, et al. Downregulation of glucocorticoid receptors of liver cytosols and the role of the inflammatory cytokines in pathological stress in scalded rats. Burns 2002;28:315-320.
29. Li Y. Relationship between glucocorticoid receptor and deficiency syndrome and the regulation of traditional Chinese medicine. J Chin Integr Med 2004;2:172-174.
30. Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: Multiple constituents and multiple actions. Biochem Pharmacol 1999;58:1685-1693.
31. Lee YJ, Chung E, Lee KY, et al. Ginsenoside-Rg1, one of the major active molecules from Panax ginseng, is a functional ligand of glucocorticoid receptor. Mol Cell Endocrinol 1997;133:135-140.
32. Ling C, Li Y, Zhu X, et al. Ginsenosides may reverse the dexamethasone-induced down-regulation of glucocorticoid receptor. Gen Comp Endocr 2005;140:203-209.
33. Li M, Ling CQ, Huang XQ, Shen ZL. Effects of ginsenosides extracted from ginseng stem and leaves on glucocorticoid receptor in different viscera in heat-damaged rats. Zhong Xi Yi Jie He Xue Bao 2006;4:156-159.